Year-end Sale % OFF 
Abstract
Metabolomics is an emerging field in biomarker discovery. Metabolites, which are small molecules with molecular weight less than 1.5kDa, have been found to be useful for early disease diagnosis and prediction for therapy, prognosis, and monitor treatment. Metabolites provide information on the real-time applications in clinical settings. Nevertheless, a number of challenges exist in the clinical settings. Despite the challenges, metabolomics is considered as a useful tool for biomarker and drug discovery. In this chapter, we will discuss the metabolites that have been identified as potential biomarker for cardiovascular disease and diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
